Nasdaq

Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development

New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications ...
Nasdaq

Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery

EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and ...
Business Insider

Berkeley Lights Makes Debut in Taiwan as Mycenax Acquires the BeaconⓇ Optofluidic System for Cell Line Development

MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the ...
KRON4 News

Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody ...

EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & ...
News Medical

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s ...
News Medical

Berkeley Lights launches Beacon Select™, a new optofluidic system for cell line development

Berkeley Lights, Inc., a life sciences tools company, today announced the launch of the Beacon Select ™, the company's new optofluidic system for cell line development (CLD). The Beacon Select builds ...